Table 2.
Demographics, clinical and laboratory data
| All patients (n=24) | Immune DAH (n=11) | Nonimmune DAH (n=13) | P | |
| Age, years | 62,7±18,9 | 56,6±18,8 | 67,9±18,1 | 0,042 |
| Male gender | 15 (62,5) | 7 (63,6) | 8 (61,5) | 1,000 |
| Smoking history | 6 (25,0) | 4 (36,4) | 2 (15,4) | 0,357 |
| Alcohol abuse | 1 (4,2) | 1 (9,1) | 0 (0) | 0,458 |
| Known cardiac disease | 16 (66,7) | 6 (54,5) | 10 (76,9) | 0,390 |
| Known respiratory disease | 8 (33,3) | 5 (45,5) | 3 (23,1) | 0,390 |
| DAH triad | 9 (37,5) | 4 (36,4) | 5 (38,5) | 1,000 |
| Hemoptysis | 16 (66,7) | 6 (54,5) | 10 (76,9) | 0,390 |
| Pulmonary infilitrates | 24 (100) | 11 (100) | 13 (100) | - |
| Anemia | 19 (79,2) | 10 (90,9) | 9 (69,2) | 0,294 |
| Hematuria | 8 (33,3) | 7 (63,6) | 1 (7,7) | 0,008 |
| Proteinuria | 8 (33,3) | 8 (72,7) | 0 (0) | <0,001 |
| Kidney failure | 10 (41,7) | 7 (63,6) | 3 (23,1) | 0,048 |
| Pulmonary-renal syndrome | 7 (29,2) | 7 (63,6) | 0 (0) | <0,001 |
| Thrombocytopenia | 4 (16,7) | 3 (27,3) | 1 (7,7) | 0,300 |